tiprankstipranks
Advertisement
Advertisement

Integra LifeSciences raises FY26 adjusted EPS to $2.40-$2.50 from $2.30-$2.40

FY26 consensus $2.35. Backs FY26 revenue view $1.66B-$1.702B, consensus $1.67B. EPS guidance reflects the first quarter benefits from the IEEPA tariffs.

Meet Samuel – Your Personal Investing Prophet

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1